Persistent Asset Partners »

Adagio Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $170k 69k 2.47

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Adagio Therapeutics

Henderson Group
Maverick Capital
RA Capital Management
Point72 Asset Management
Mithril II GP
Vanguard Group
Driehaus Capital Management
M28 Capital Management
Saturn V Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
Siren
ADAR1 Capital Management
BlackRock

View all funds holding Adagio Therapeutics